Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pergolide versus tolcapone for cognitive deficits in schizophrenia
2008-006905-18Phase 4Terminated
- Sponsor
- RWTH Aachen University
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia comparing Pergolide add-on, Tolcapone add-on and Placebo add-on (3 arms). Primary endpoint: Neuropsychological test results. Started Jul 2010; status: terminated.
02
Drugs
pergolidetolcapone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2008-006905-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006905-18.